NCT07301268 2026-02-03GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaMayo ClinicPhase 2 Suspended36 enrolled
NCT05669352 2025-04-04A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain MetastasesUniversity of FloridaPhase 1/2 Suspended29 enrolled